Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aquivia Health vs Vitara RX

Aquivia Health
Graded #81

Lower grade

vs+13.799999999999997
Vitara RX
Graded #16

Higher grade

The verdict

Vitara RX takes it — 86/100 to 72.2/100.

Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sub-$100 semaglutide and $149 tirzepatide — both molecules, verified and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitara RX +7
86
93
Dose & formulationAquivia Health +5
85
80
Clinical oversightVitara RX +21
64
85
Labs & monitoringVitara RX +30
53
83
FulfillmentVitara RX +16
71
87
Contract termsVitara RX +31
55
86
Aquivia Health · left barVitara RX · right bar

The numbers

MetricAquivia HealthVitara RX
WeighScore72.2/10086/100
GradeCB
Scorecard rank#81#16
Semaglutide$149/mo$99/mo
Tirzepatide$179/mo$149/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Aquivia Health

Graded #81 · C

Strengths

  • Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
  • Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
  • Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
  • Both compounded and branded GLP-1s offered side by side — unusual for a compounded provider
  • Self-pay model with no insurance required and no separate consultation fee

Where it loses points

  • No public list of states served — you must complete intake to learn if your state qualifies
  • No named 503A compounding pharmacy partner, limiting licensure verification
  • No LegitScript, PCAB, or BBB trust badges visible
  • Brand confusion: site schema names 'CatalystMD' while the customer-facing brand is Aquivia Health
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Vitara RX

Graded #16 · B

Strengths

  • $99 sema / $149 tirz — bottom-quartile pricing
  • Both molecules, all 50 states
  • LegitScript-verified

Where it loses points

  • Injection-only, no oral route
  • Labs/monitoring not detailed
  • Newer, thinner track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard